Peptides as key components in the design of non-viral vectors for gene delivery

被引:6
|
作者
Thomas, Joseph [1 ]
Punia, Kamia [1 ]
Montclare, Jin Kim [1 ,2 ,3 ,4 ]
机构
[1] New York Univ Tandon, Dept Chem & Biomol Engn, Sch Engn, Brooklyn, NY USA
[2] Suny Downstate Med Ctr, Dept Biochem, Brooklyn, NY 11203 USA
[3] NYU, Dept Chem, New York, NY USA
[4] NYU, Coll Dent, Dept Biomat, New York, NY USA
基金
美国国家卫生研究院;
关键词
biomaterials; gene delivery; peptide; polypeptide; nucleic acid; CELL-PENETRATING PEPTIDES; IN-VIVO; PROTEIN TRANSDUCTION; TAT-PEPTIDE; ENDOTHELIAL-CELLS; ENDOSOMAL ESCAPE; SIRNA DELIVERY; GROWTH-FACTOR; PLASMID DNA; CANCER;
D O I
10.1002/pep2.24189
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Successful clinical implementation of gene delivery relies on the use of viral or non-viral based vectors to package and protect the therapeutic nucleic acid. These vehicles must also be able to direct the fate of the cargo once it has entered the cell to ensure that the nucleic acid is functional, and the desired outcome is achieved. Compared to viral vectors, non-viral vectors have the advantage of incorporating different material types such as lipids, polymers, and peptides to tune overall safety and efficacy. Peptides are especially powerful when used in gene delivery vectors as they are able to increase gene delivery efficacy by introducing new biochemical functionality. This review will discuss the use of peptides as central design components in non-viral gene delivery vectors. The contribution of the peptide component to the overall functionality of the delivery vehicle will be highlighted, with a focus on peptides as the only vehicle component or peptides in complex assemblies with lipids or polymers.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] Dendrimers as non-viral vectors for siRNA delivery
    Liu, Xiaoxuan
    Rocchi, Palma
    Peng, Ling
    NEW JOURNAL OF CHEMISTRY, 2012, 36 (02) : 256 - 263
  • [32] Local siRNA delivery by non-viral vectors
    Beilvert, F.
    Mevel, M.
    Chatin, B.
    Pitard, B.
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2012, 22 (01) : 17 - 27
  • [33] Basic peptides as functional components of non-viral gene transfer vehicles
    Nakanishi, M
    Eguchi, A
    Akuta, T
    Nagoshi, E
    Fujita, S
    Okabe, J
    Senda, T
    Hasegawa, M
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2003, 4 (02) : 141 - 150
  • [34] Viral and non-viral vectors for cancer gene therapy
    Cristiano, RJ
    ANTICANCER RESEARCH, 1998, 18 (5A) : 3241 - 3245
  • [35] Gene delivery by Non-viral vectors: An attempt to get through barrier in gene transfer
    Jyotsna, N. Lalitha
    Saritha, N.
    RESEARCH JOURNAL OF BIOTECHNOLOGY, 2019, 14 (04): : 124 - 129
  • [36] Immune Responses to Gene Editing by Viral and Non-Viral Delivery Vectors Used in Retinal Gene Therapy
    Ren, Duohao
    Fisson, Sylvain
    Dalkara, Deniz
    Ail, Divya
    PHARMACEUTICS, 2022, 14 (09)
  • [37] Non-viral is superior to viral gene delivery
    Li, Shyh-Dar
    Huang, Leaf
    JOURNAL OF CONTROLLED RELEASE, 2007, 123 (03) : 181 - 183
  • [38] Design of lipospermine non-viral gene delivery vectors for self-assembly DNA nanoparticle formulations
    Ghonaim, H. M.
    Li, S.
    Pourzand, C.
    Blagbrough, I. S.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2006, 58 : A7 - A7
  • [39] Influence surface modification of lipoplexes on the pharmacokinetics of non-viral vectors for gene delivery
    Perouzel, E
    Caussin, A
    Ulrich, K
    Miller, AD
    Coutelle, C
    Keller, M
    Jorgensen, M
    MOLECULAR THERAPY, 2004, 9 : S185 - S185
  • [40] Trimethylated chitosans as non-viral gene delivery vectors: Cytotoxicity and transfection efficiency
    Kean, T
    Roth, S
    Thanou, M
    JOURNAL OF CONTROLLED RELEASE, 2005, 103 (03) : 643 - 653